IL1B and Hepatic steatosis: It has been reported that Caspase-1 activity and mature IL-1β levels are significantly increased in steatohepatitis models (104), and NLRP3 inflammasome activation aggravates hepatic steatosis, liver inflammation, and fibrogenesis, supporting the contribution of NLRP3 inflammasome to pathogenesis of fatty liver disease (105).